EMPYREAN THERAPEUTICS CHANGING RADIATION ONCOLOGY. FOR GOOD. Trademark

Trademark Overview


On Wednesday, December 6, 2023, a trademark application was filed for EMPYREAN THERAPEUTICS CHANGING RADIATION ONCOLOGY. FOR GOOD. with the United States Patent and Trademark Office. The USPTO has given the EMPYREAN THERAPEUTICS CHANGING RADIATION ONCOLOGY. FOR GOOD. trademark a serial number of 98301621. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 25, 2025. This trademark is owned by Empyrean Medical Systems, Inc.. The EMPYREAN THERAPEUTICS CHANGING RADIATION ONCOLOGY. FOR GOOD. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer in concert with radiation oncology devices or as stand-alone formulations; drug delivery agents consisting of nanoparticle compounds that facilitate delivery of pharmaceuticals for treating cancer in concert with radiation oncology devices or as stand-alone formulations
empyrean therapeutics changing radiation oncology. for good.

General Information


Serial Number98301621
Word MarkEMPYREAN THERAPEUTICS CHANGING RADIATION ONCOLOGY. FOR GOOD.
Filing DateWednesday, December 6, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 25, 2025

Trademark Statements


Description of MarkThe mark consists of three chevrons above four hexagons arranged in a y-shaped pattern that are above the word "EMPYREAN" which is above the word "THERAPEUTICS", all of which are above the wording "CHANGING RADIATION ONCOLOGY. FOR GOOD." in a script font.
Goods and ServicesPharmaceutical preparations for the treatment of cancer in concert with radiation oncology devices or as stand-alone formulations; drug delivery agents consisting of nanoparticle compounds that facilitate delivery of pharmaceuticals for treating cancer in concert with radiation oncology devices or as stand-alone formulations
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEmpyrean Medical Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33431

Party NameEmpyrean Medical Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33431

Trademark Events


Event DateEvent Description
Wednesday, December 6, 2023NEW APPLICATION ENTERED
Tuesday, March 5, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 5, 2024ASSIGNED TO EXAMINER
Tuesday, July 30, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 30, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 28, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 28, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 31, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, October 11, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, July 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 11, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED